tenk.fyi

Vericel Corp

VCELNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$276.3M

16.5% YoY

Net Income

$16.5M

59.4% YoY

EPS

$0.32

60.0% YoY

Cash

$100.1M

34.3% YoY

FY 2025 · As of 2025-12-31